Custom breast shell could make radiation therapy faster and more comfortable
NCT ID NCT07711847
First seen Jul 17, 2026 · Last updated Jul 17, 2026
Summary
This trial tests whether a custom-made breast holder called VENUS SHELL™ can improve positioning and comfort during radiotherapy for early-stage breast cancer. Participants lie on their stomach while the device holds the breast in place, aiming to deliver precise radiation in shorter sessions. The study enrolls women aged 40 and older who have had breast-conserving surgery and need radiotherapy.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- a personalized breast holder called VENUS SHELL™ used during radiotherapy
- What this could lead to
- If successful, this device could make radiotherapy faster, more accurate, and more comfortable for women with early-stage breast cancer.
- What could go wrong
- This is a small early-stage study focused on feasibility and safety, so the device may not prove beneficial or practical in routine care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DUCTAL CARCINOMA IN SITU, DCIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
NYU Grossman School of Medicine
RECRUITINGNew York, New York, 10016, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.